Fig. 3From: Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysisRisk of bias assessment (RoB 2) at outcome level of the randomized clinical trials included. a - ACR 50 and PsARC; b - Serious adverse eventsBack to article page